4-(3-Bromophenyl)-2,6-diphenylpyrimidine(CAS: 864377-28-6)

4-(3-Bromophenyl)-2,6-diphenylpyrimidine (CAS: 864377-28-6) falls under the scope of GHS (Globally Harmonized System of Classification and Labelling of Chemicals) for hazardous communication. It must comply with REACH regulations in the European Union, which require registration, evaluation, authorization, and restriction of substances. In the United States, it is subject to FDA (Food and Drug Administration) and EPA (Environmental Protection Agency) regulations for chemical substances and industrial purposes.

Several alternatives to 4-(3-Bromophenyl)-2,6-diphenylpyrimidine can be used in synthesis, depending on the desired properties. Common substitutes include other pyrimidine derivatives with different substituents, such as 4-(4-bromophenyl)-2,6-diphenylpyrimidine or 4-(2-bromophenyl)-2,6-diphenylpyrimidine. These alternatives may offer varying levels of reactivity and biological activity, making them suitable for different applications.

The market for 4-(3-Bromophenyl)-2,6-diphenylpyrimidine (CAS: 864377-28-6) is growing due to its potential in pharmaceutical and agrochemical industries. Research trends focus on its use as an intermediate in drug synthesis and as a potential antiviral and anticancer agent. Emerging studies are exploring its efficacy in treating various diseases, driving market demand and innovation.

Waste containing 4-(3-Bromophenyl)-2,6-diphenylpyrimidine (CAS: 864377-28-6) should be collected and stored in appropriate containers to prevent spillage and ensure safety. It is recommended to neutralize the waste with an appropriate base or acid, followed by incineration or professional hazardous waste disposal services. Proper environmental protection measures, such as containment and monitoring, should be implemented to minimize environmental impact.